VectorY Therapeutics
PrivateLast Round
Series A
Nov 13, 2023
Total Funding Raised
$176M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
VectorY Therapeutics is a biotechnology company that develops vectorized antibody therapies for neurodegenerative diseases including ALS, Huntington's, and Parkinson's disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
VectorY Therapeutics Comparables
Compare VectorY Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Capsida Biotherapeutics | 81% | |
| Coave Therapeutics | 77% | |
| Voyager Therapeutics | 76% |
VectorY Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Nov 13, 2023 | ||||
| Seed | Jun 15, 2021 |
Key People
Founding team and executive leadership
VectorY Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| EQT Life Sciences | Series A |
| Forbion | Series A, Seed |
| ALS Investment Fund | Series A |
| BioGeneration Ventures | Series A, Seed |
| Insight Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 43% MoM, reaching 6.6K.
- Dec 16, 2025
Developing vectorized antibody therapies with Shape Therapeutics.
VectorY Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about VectorY Therapeutics's valuation, stock price, and market status.
Is VectorY Therapeutics a public or private company?
VectorY Therapeutics is a private company.
What is the current stock price of VectorY Therapeutics?
VectorY Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is VectorY Therapeutics worth (valuation)?
Valuation information for VectorY Therapeutics is not publicly available.
Can I buy VectorY Therapeutics stock?
VectorY Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was VectorY Therapeutics's last funding round?
VectorY Therapeutics's most recent funding round was Series A on November 13, 2023.
Who are the main investors in VectorY Therapeutics?
Key investors in VectorY Therapeutics include EQT Life Sciences, Forbion.
Will VectorY Therapeutics IPO soon?
No public IPO plans have been announced for VectorY Therapeutics.
How can I track VectorY Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor VectorY Therapeutics's secondary market activity and sign up for updates.